Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate
- PMID: 1730492
- PMCID: PMC257668
- DOI: 10.1128/iai.60.2.584-589.1992
Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate
Abstract
Staphylococcus aureus type 8 capsular polysaccharide (CP) was conjugated either to diphtheria toxoid or to Pseudomonas aeruginosa recombinant exoprotein A by using adipic acid dihydrazide (ADH) or N-succinimidyl-3-(2-pyridyldithio)propionate (SPDP) as the joining reagent. The polysaccharide/protein ratios of these two pairs of conjugates were similar. The two synthetic schemes bound the linker to the carboxyls of the type 8 CP by carbodiimide-mediated condensation. ADH was bound to the carboxyls of the protein, whereas SPDP reacted with the amino groups of the protein. Intermolecular linking of the carrier protein, caused by the carbodiimide during the conjugation reaction with the type 8 CP derivative, probably accounts for the larger size of the conjugates formed with ADH compared with those formed with SPDP. Both conjugates synthesized with ADH elicited higher levels of CP antibodies, especially after the first immunization, than did those prepared with SPDP. Similar levels of exoprotein A antibodies were elicited by both conjugates. Higher levels of diphtheria toxoid antibodies were elicited by the conjugate prepared with SPDP than by the one prepared with ADH. The basis for the differences in the immunogenicities of these two pairs of S. aureus type 8 CP conjugates is discussed.
Similar articles
-
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.Infect Immun. 1993 Mar;61(3):1023-32. doi: 10.1128/iai.61.3.1023-1032.1993. Infect Immun. 1993. PMID: 8432585 Free PMC article.
-
Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides.Vaccine. 1995 Oct;13(14):1288-93. doi: 10.1016/0264-410x(95)00052-3. Vaccine. 1995. PMID: 8585282
-
Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A.Infect Immun. 1990 Jul;58(7):2367-74. doi: 10.1128/iai.58.7.2367-2374.1990. Infect Immun. 1990. PMID: 2114365 Free PMC article.
-
Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins.Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S644-9. doi: 10.1093/clinids/9.supplement_5.s644. Rev Infect Dis. 1987. PMID: 3120274 Review.
-
Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.Vaccine. 1993;11 Suppl 1:S46-51. doi: 10.1016/0264-410x(93)90160-y. Vaccine. 1993. PMID: 8447176 Review.
Cited by
-
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.Infect Immun. 1999 Nov;67(11):5806-10. doi: 10.1128/IAI.67.11.5806-5810.1999. Infect Immun. 1999. PMID: 10531232 Free PMC article.
-
Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.Infect Immun. 2001 Jan;69(1):297-306. doi: 10.1128/IAI.69.1.297-306.2001. Infect Immun. 2001. PMID: 11119518 Free PMC article.
-
Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.Infect Immun. 1995 Aug;63(8):2805-10. doi: 10.1128/iai.63.8.2805-2810.1995. Infect Immun. 1995. PMID: 7542631 Free PMC article.
-
Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.Infect Immun. 1994 Jan;62(1):210-4. doi: 10.1128/iai.62.1.210-214.1994. Infect Immun. 1994. PMID: 8262629 Free PMC article.
-
Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.Infect Immun. 1993 Mar;61(3):1023-32. doi: 10.1128/iai.61.3.1023-1032.1993. Infect Immun. 1993. PMID: 8432585 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous